UOB KAYHIAN | CGS CIMB |
Potential Unlocking Of Huge Value Via Nasdaq Listing Of Associated Company Aoxin’s 49% associated company, Acumen, is exploring a listing on Nasdaq. Our basecase estimate using 22x 2021F PE for Acumen, based on Q&M Dental’s historical mean PE, will unlock value of S$216m (S$0.42/share) for Aoxin. Compared to current market cap of Aoxin at S$127m (S$0.25/share), shareholders will enjoy more than 70% upside in value accretion upon successful of listing, with continued ownership of the China dental business. Maintain BUY and target price of S$0.37 (16x 2022F PE). |
Keppel Corporation
|
MAYBANK KIM ENG |
UOB KAYHIAN |
Axis REIT (AXRB MK)
|
Sentral REIT (SENTRAL MK)
|